Phase I: Primary Research Objective: Evaluate the safety, tolerability, and pharmacokinetic characteristics of a single dose of DGPR1008 in healthy subjects. Secondary Research Objective: Based on the safety and pharmacokinetic results, assess the maximum tolerated dose (MTD) and the recommended phase II dose (RP2D) of DGPR1008.
Age range
18 Years – 65 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Incidence of Treatment-Emergent Adverse Events
Timeframe: through study completion, an average of 5 Days
Number of participants with abnormal vital signs
Timeframe: through study completion, an average of 5 Days
Number of participants with abnormal vital signs
Timeframe: through study completion, an average of 5 Days
Number of participants with abnormal vital signs
Timeframe: through study completion, an average of 5 Days
The number of participants with abnormal BMI
Timeframe: through study completion, an average of 5 Days
Number pf participants with abnormal laboratory tests results
Timeframe: through study completion, an average of 5 Days
Number pf participants with abnormal laboratory tests results
Timeframe: through study completion, an average of 5 Days
Number pf participants with abnormal laboratory tests results
Timeframe: through study completion, an average of 5 Days